Monitoring the progression of cancer in patients is important, but current biomarker diagnostic kits are either expensive or not sensitive enough. A team of Maltese researchers came up with an idea to produce sensitive yet low-cost kits to solve this problem.This led to the start of a three-year project called FABXS – Development of a...
